Senior insider sale
Chief Medical Officer at BETA BIONICS, INC. — senior position signals high conviction
$135.2K
8.44K shares
What this filing means
RUSSELL STEVEN JON plans to sell 8.44K shares of BETA BIONICS, INC. valued at approximately $135.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/3/2026ACC: 0002051384-26-000008
Officer· Chief Medical Officer
Since Feb 2026
8.44K
Shares to sell
$135.2K
Approx. market value
4.22K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units vesting under registered plan
Compensation for services rendered to Issuer
9/1/2026
4.22KTotal acquired4.22K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | Restricted Stock Units vesting under registered plan Compensation for services rendered to Issuer | 4.22K | — |
| Total | 4.22K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.22K
Market value
$53.2K
6/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.22K
Market value
$82.0K
9/2/2026
Total
Units
8.44K
Value
$135.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/2/2026 | 4.22K | $53.2K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2026 | 4.22K | $82.0K | NASDAQ | Planned |
| Total | 8.44K | $135.2K | ||